Search results for "Highlights"


 
Results 81 - 90 of about 316 for "Highlights".

Preoperative glucose levels may predict postoperative cardiac outcomes regardless of whether patients have diabetes

For patients without diabetes, predictors of myocardial injury after noncardiac surgery included a casual glucose level of more than 6.86 mmol/L (124 mg/dL) and a fasting glucose level of more than 6.41 mmol/L (116 mg/dL).
August 2018

Intermittent fasting appears effective for HbA1c reduction in type 2 diabetes

Patients on the intermittent energy restriction diet ate 500 to 600 kcal/d on two nonconsecutive days each week and followed their usual diet on the other days. They were compared to a group eating 1,200 to 1,500 kcal/d.
August 2018

Basal insulin analogs and NPH insulin had similar rates of hypoglycemia hospital visits, glycemic control in type 2 diabetes

Researchers used data from Kaiser Permanente of Northern California to retrospectively assess patients with type 2 diabetes who initiated a long-acting insulin analog or NPH insulin between Jan. 1, 2006, and Sept. 30, 2015.
July 2018

SGLT2 inhibitors, GLP-1 agonists associated with lower mortality compared to DPP-4 inhibitors, analysis finds

Glucagon-like peptide-1 (GLP-1) agonists were associated with a higher risk of adverse events than sodium-glucose cotransporter-2 (SGLT2) inhibitors or dipeptidyl peptidase 4 (DPP-4) inhibitors, according to the meta-analysis.
May 2018

Spotlight on depression in diabetes

The results highlight the importance of psychosocial interventions for at-risk patients, they concluded.
November 2018

Study finds potential early indicators of myocardial dysfunction in asymptomatic elderly patients with type 2 diabetes

Researchers examined asymptomatic patients 65 years of age and older with type 2 diabetes and preserved left ventricular ejection fraction to look for impaired global longitudinal strain, diastolic dysfunction, or left atrial enlargement.
June 2018

Beta-blockers associated with mortality risk in patients with diabetes, study finds

Patients with diabetes who were taking any beta-blocker, a beta-1 selective beta-blocker, or a specific beta-blocker had significantly higher risk for all-cause mortality versus patients with diabetes who were not taking a beta-blocker.
April 2018

Diabetes treatment in the elderly has improved, but complex regimens still common, study finds

Between 2007 and 2014, more Medicare beneficiaries were newly prescribed metformin, dipeptidyl peptidase-4 inhibitors, and sodium-glucose cotransporter 2 inhibitors, while fewer received long-acting sulfonylureas or thiazolidinediones.
March 2018

Inpatient management by a diabetes team associated with improved readmissions, reduced cost

The retrospective study at a single tertiary care referral medical center compared cost-effectiveness of care from a specialized diabetes team with care from a primary service team.
April 2018

Review: Evidence is inconclusive on metabolic surgery vs. medical treatment for microvascular complications in T2DM

They also highlight the need for further RCTs assessing the effect of metabolic surgery on microvascular diabetes outcomes.
August 2018

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next